{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:05:33Z","timestamp":1785229533938,"version":"3.55.0"},"reference-count":49,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Acute elevation in circulating lipids induces reversible insulin resistance and alters triglyceride-rich lipoprotein flux. Whether insulin-regulated remodelling of high-density lipoprotein (HDL)-associated apolipoproteins is altered during defined lipid stress in women with polyendocrine metabolic ovarian syndrome (PMOS) remains unclear. In this exploratory, randomized, cross-over study, 10 healthy women and 12 women with PMOS underwent 5-h saline or lipid infusion, with a hyperinsulinemic\u2013euglycemic clamp commencing at 180 min. Plasma proteomics were performed at baseline, 180 min and 300 min using linear modelling (limma). Lipid infusion induced the coordinated suppression of ApoA1 and ApoE isoforms at 180 min in both groups (FDR-adjusted p &lt; 0.01), followed by partial recovery during hyperinsulinemia. Women with PMOS exhibited greater early suppression of ApoA1 (log2 fold-change \u22122.20, p = 0.001) and more persistent suppression of ApoE isoforms at 300 min (ApoE3 log2 \u22121.64, p = 0.001). ApoA1 suppression correlated inversely with NEFA exposure during lipid infusion (Spearman \u03c1 = \u22120.54, p = 0.021). Controlled lipid challenge reveals amplified but reversible dysregulation of HDL-associated apolipoproteins in PMOS, with the preservation of the overall response pattern, but impaired recovery under hyperinsulinemic conditions. These findings suggest impaired adaptation to acute lipid stress in PMOS, with ApoA1 changes appearing to relate more closely to acute NEFA exposure than to clamp-derived insulin sensitivity.<\/jats:p>","DOI":"10.3390\/ijms27156656","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:47:41Z","timestamp":1785145661000},"page":"6656","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid Challenge Reveals Amplified Apolipoprotein Responses with Preserved Temporal Pattern in Polyendocrine Metabolic Ovarian Syndrome: An Exploratory Study"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0085-5338","authenticated-orcid":false,"given":"Ebrahim","family":"Rajab","sequence":"first","affiliation":[{"name":"Royal College of Surgeons of Ireland, Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Saleh Md","family":"Moin","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons of Ireland, Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Nandakumar","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons of Ireland, Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-2231","authenticated-orcid":false,"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons of Ireland, Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-7257","authenticated-orcid":false,"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons of Ireland, Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic Flexibility in Health and Disease","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00211","article-title":"Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease","volume":"39","author":"Smith","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_3","first-page":"46","article-title":"Plasma Non-Esterified Fatty Acids (NEFA) in Type 2 Diabetes Mellitus: Evidence on Pathophysiology","volume":"3","author":"Chandra","year":"2021","journal-title":"J. Diabetes Clin. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of Insulin Action and Insulin Resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Aye, M.M., Butler, A.E., Kilpatrick, E.S., Kirk, R., Vince, R., Rigby, A.S., Sandeman, D., and Atkin, S.L. (2018). Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00592"},{"key":"ref_6","first-page":"E214","article-title":"Glucose clamp technique: A method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am. J. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-023-01860-w","article-title":"Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: A systematic review and meta-analysis","volume":"22","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","author":"Yang","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kiss, I., Neuwert, N., Oberle, R., Hengstschlager, M., Osmanagic-Myers, S., and Stangl, H. (2025). Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems. Biomolecules, 15.","DOI":"10.3390\/biom15070956"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.4103\/NRR.NRR-D-23-01470","article-title":"Isoform- and cell-state-specific APOE homeostasis and function","volume":"19","author":"Lindner","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s43556-024-00218-7","article-title":"The functions of apolipoproteins and lipoproteins in health and disease","volume":"5","author":"Ma","year":"2024","journal-title":"Mol. Biomed."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1210\/clinem\/dgad031","article-title":"The Impact of Acute Nutritional Interventions on the Plasma Proteome","volume":"108","author":"Vernardis","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ordonez-Llanos, J., and Escola-Gil, J.C. (2024). Apolipoproteins in Health and Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137048"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Varlamov, O., Bethea, C.L., and Roberts, C.T. (2015). Sex-specific differences in lipid and glucose metabolism. Front. Endocrinol., 5.","DOI":"10.3389\/fendo.2014.00241"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100479","DOI":"10.1016\/j.metop.2026.100479","article-title":"What\u2019s in a name? From PCOS to polyendocrine metabolic ovarian syndrome: A metabolic reframing, promise, controversies, and challenges ahead","volume":"30","author":"Dalamaga","year":"2026","journal-title":"Metab. Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40124-025-00364-8","article-title":"Metabolic Implications of PCOS","volume":"13","author":"Naveed","year":"2025","journal-title":"Curr. Pediatr. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"He, H., Feng, J., Zhang, S., Wang, Y., Li, J., Gao, J., Cong, J., Gong, Y., and Wu, X. (2022). The Apolipoprotein B\/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.773781"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Butler, A.E., Moin, A.S.M., Reiner, \u017d., Sathyapalan, T., Jamialahmadi, T., Sahebkar, A., and Atkin, S.L. (2023). HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study. Cells, 12.","DOI":"10.3390\/cells12060855"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1111\/dom.70154","article-title":"Shared and divergent acute cardiovascular risk protein responses to lipid infusion in women with and without PCOS","volume":"27","author":"Rajab","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhu, M., Wang, K., Feng, J., Liu, Y., Guan, M., Wang, Y., and Wu, X. (2024). The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1502321"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chavez-Diaz, M.F., Ortiz-Rodriguez, B., De Leon, L.G., Candia-Lujan, R., and Carrasco-Legleu, C.E. (2025). Physical Exercise on Aerobic Capacity in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Am. J. Lifestyle Med., 1\u201315.","DOI":"10.1177\/15598276251372517"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, W., Zhao, J., Jiao, P., Zeng, L., Zhang, H., Zhao, Y., Shi, L., Hu, H., and Luo, L. (2022). Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1085656"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.32771\/inajog.v12i1.2031","article-title":"Body Composition Parameters, Adiponectin, Leptin and Adiponectin\/Leptin Ratio are Correlated with LH\/FSH Ratio in Women with PCOS but not in Women without PCOS","volume":"12","author":"Pratama","year":"2024","journal-title":"Indones. J. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","article-title":"Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics","volume":"154","author":"Bhale","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"118614","DOI":"10.1016\/j.atherosclerosis.2024.118614","article-title":"Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia","volume":"398","author":"Luo","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.fertnstert.2024.01.030","article-title":"Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome","volume":"121","author":"Ezeh","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/eurheartj\/ehad161","article-title":"Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction","volume":"44","author":"Nurmohamed","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1016\/j.cell.2025.05.005","article-title":"Personalized molecular signatures of insulin resistance and type 2 diabetes","volume":"188","author":"Stocks","year":"2025","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wang, W., Chen, Y., Tu, M., and Chen, H.J. (2024). Triglycerides to apolipoprotein A1 ratio: An effective insulin resistance-associated index in identifying metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1384059"},{"key":"ref_34","unstructured":"American Diabetes Association Professional Practice Committee (2024). Summary of Revisions: Standards of Care in Diabetes-2024. Diabetes Care, 47, S5\u2013S10."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"167806","DOI":"10.1016\/j.bbadis.2025.167806","article-title":"Lipidomics and cardiovascular disease","volume":"1871","author":"Surendran","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","article-title":"Plasma protein patterns as comprehensive indicators of health","volume":"25","author":"Williams","year":"2019","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-019-0791-9","article-title":"Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD","volume":"21","author":"Taskinen","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for Investigating Physiological and Pathophysiological Processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"108588","DOI":"10.1016\/j.compbiomed.2024.108588","article-title":"Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"176","author":"Naccache","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"eabm5164","DOI":"10.1126\/sciadv.abm5164","article-title":"Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods","volume":"8","author":"Katz","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/dom.14220","article-title":"Hypoglycaemia in type 2 diabetes exacerbates amyloid-related proteins associated with dementia","volume":"23","author":"Moin","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"BMJ"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11306-021-01806-2","article-title":"Differential insulin sensitivity of NMR-based metabolomic measures in a two-step hyperinsulinemic euglycemic clamp study","volume":"17","author":"Wang","year":"2021","journal-title":"Metabolomics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav. Brain Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6656\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:52:16Z","timestamp":1785228736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":49,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156656"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156656","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]}}}